Nanoray-312：NBTXR3联合放疗±西妥昔单抗治疗老年、铂类不适用的局部晚期头颈部鳞状细胞癌的III期研究。
Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC.
作者信息
Le Tourneau Christophe, Takácsi-Nagy Zoltán, Nuyts Sandra, Thureau Sébastien, Liu Feng, Hoffmann Caroline, Hackman Trevor G, Lesnik Maria, Debard Anaïs, Finzi Laetitia, Devisetty Kiran, Vivar Omar I, Farber Leonard A, Nguyen France, Liem Xavier, Natelauri Eteri, Psyrri Amanda, Burian Martin, Yu Jinming, Yom Sue S
机构信息
Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France.
Center of Radiotherapy and National Tumorbiology Laboratory, National Institute of Oncology and Department of Oncology, Semmelweis University, Budapest, Hungary.
出版信息
Future Oncol. 2025 May;21(12):1489-1499. doi: 10.1080/14796694.2025.2496131. Epub 2025 May 5.
https://clinicaltrials.gov identifier is NCT04892173; EudraCT Number: 2021-002163-22.
美国国立医学图书馆临床试验注册中心标识符为NCT04892173；欧盟临床试验数据库编号：2021-002163-22。
Zotero 插件